Cargando…
Blood cell counts can predict adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis
BACKGROUND: Cancer is concerning owing to its high mortality rate. Consequently, methods of prolonging the life of patients with cancer have become the primary focus of attention research. In recent years, immune checkpoint inhibitors (ICIs) have achieved good clinical efficacy as antitumor drugs; h...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029759/ https://www.ncbi.nlm.nih.gov/pubmed/36960068 http://dx.doi.org/10.3389/fimmu.2023.1117447 |